Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Integrating claims/clinical data may enhance cost estimates for cancer therapy
January 5th, 2006
Integrating managed care claims data and clinical data may enhanced cost burden estimates for cancer therapy. "In the U.S., the majority of premenopausal patients with early-stage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopausal women," researchers in the United States asserted. "The objective of [our] study was to evaluate the direct medical cost of adjuvant chemotherapy in women with early-stage breast carcinoma," N. Oestreicher and colleagues explained. "The attributable cost of adjuvant...
Source: Women's Health Weekly (2006-01-05)
|
